CastleVax Inc.: Clinical Trials

1 trial sponsored by CastleVax Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow CastleVax Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults
NDV-HXP-S-KP.2, COVID-19 mRNA Vaccine - COVID-19
Phase 2Active not recruitingCastleVax Inc.2002025-11-032026-07-22

Conditions studied

COVID-19 (1)

Interventions

CVnCoV COVID-19 vaccine (1)

Countries

United States (1)

Top investigators

Michael Egan, PhD (1)